The pharmacology of antihypertensive drugs with special reference to vasodilators, alpha-adrenergic blocking agents and prazosin.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D002346:Carotid Sinus / Q000187:drug effects; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D066298:In Vitro Techniques; D009638:Norepinephrine / Q000378:metabolism; D010643:Phenoxybenzamine / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology*; D011651:Pulmonary Artery / Q000378:metabolism; D011799:Quinazolines / Q000494:pharmacology*; D011817:Rabbits; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D012083:Renin / Q000378:metabolism; D014665:Vasodilator Agents / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D011799:Quinazolines; D011942:Receptors, Adrenergic, alpha; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D012083:Renin; D009638:Norepinephrine; D011224:Prazosin; D004837:Epinephrine